Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis
Autor: | Mainthan Palendira, Yingju Xia, Patrick Bertolino, Warwick J. Britton, John Stambas, Carl G. Feng, Manuela Flórido, James A. Triccas, Leon C. W. Lin, Frederic Sierro, H. Muflihah |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Lung Tuberculosis biology business.industry Immunology medicine.disease_cause biology.organism_classification medicine.disease law.invention Mycobacterium tuberculosis 03 medical and health sciences 030104 developmental biology medicine.anatomical_structure Immunization law Parenchyma Influenza A virus medicine biology.protein Recombinant DNA Immunology and Allergy Antibody business |
Zdroj: | Mucosal Immunology. 11:1743-1752 |
ISSN: | 1933-0219 |
DOI: | 10.1038/s41385-018-0065-9 |
Popis: | The lung is the primary site of infection with the major human pathogen, Mycobacterium tuberculosis. Effective vaccines against M. tuberculosis must stimulate memory T cells to provide early protection in the lung. Recently, tissue-resident memory T cells (TRM) were found to be phenotypically and transcriptional distinct from circulating memory T cells. Here, we identified M. tuberculosis-specific CD4+ T cells induced by recombinant influenza A viruses (rIAV) vaccines expressing M. tuberculosis peptides that persisted in the lung parenchyma with the phenotypic and transcriptional characteristics of TRMs. To determine if these rIAV-induced CD4+ TRM were protective independent of circulating memory T cells, mice previously immunized with the rIAV vaccine were treated with the sphingosine-1-phosphate receptor modulator, FTY720, prior to and during the first 17 days of M. tuberculosis challenge. This markedly reduced circulating T cells, but had no effect on the frequency of M. tuberculosis-specific CD4+ TRMs in the lung parenchyma or their cytokine response to infection. Importantly, mice immunized with the rIAV vaccine were protected against M. tuberculosis infection even when circulating T cells were profoundly depleted by the treatment. Therefore, pulmonary immunization with the rIAV vaccine stimulates lung-resident CD4+ memory T cells that are associated with early protection against tuberculosis infection. |
Databáze: | OpenAIRE |
Externí odkaz: |